Kleiner Backs Juvaris

Juvaris BioTherapeutics Inc., a Pleasanton, Calif.-based developer of vaccines for cancer and infectious diseases, has raised $7.53 million in Series A funding led by Kleiner Perkins Caufield & Byers, according to a regulatory filing. Tom Monath of KPCB will serve on the Juvaris board of directors. Juvaris had said on its website that it was seeking “$10 million to commence full-scale operations.” Company CEO Martin Cleary declined to comment. www.juvaris.com